ALAMEDA, Calif.–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has been awarded a grant of $743,345 from the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH). This award constitutes the second-year funding of a $1.6 million SBIR grant to advance BioTime’s innovative, next generation retinal restoration program addressing advanced retinal diseases […]
SANTA CLARA, Calif. Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market Agilent Technologies, Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme, Inc., a leading […]
Sierra SPR-32 Combines Highest SPR Throughput and Outstanding Sensitivity BRUSSELS — At the European SLAS 2018 meeting (www.slaseurope2018.org), Bruker today announced the launch of its new SierraTM SPR-32 system with even higher sensitivity and new instrument control software to enable highest SPR throughput with outstanding sensitivity. Powered by its new touch-compatible R3 software, the Sierra SPR-32 has innovative new features like ‘Frame Inject’ […]
QuickGene series Nucleic Acid Isolation Systems use patented ultra-thin porous membrane to realize high speed, high purity and high yield nucleic acid extraction and purification. Omaha, Nebraska and Glasgow, UK: ADS Biotec, a global leader in development of automated instruments and consumables for use in cytogenetic, pathology and research laboratories announces a strategic partnership with Kurabo […]
Oncomine TCR Beta-SR Assay for next-generation sequencing enables site-specific interrogation for T-cell receptor applications CARLSBAD, Calif. — Thermo Fisher Scientific today announced the launch of its Oncomine TCR Beta-SR Assay, a new next-generation sequencing (NGS) solution for immuno-oncology research designed to characterize T-cell clonality in the tumor microenvironment – a key approach to identify potential biomarkers associated with […]
Since the groundbreaking discovery of human induced pluripotent stem cells (hiPSCs) by Shinya Yamanaka in 2006, the use of pluripotent stem cells (PSCs) has experienced a boom. Due to their extensive in vitro self-renewal properties and their ability to differentiate into many different cell types, PSCs, and especially hiPSCs, offer exciting promises in a wide […]
Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market L: Stefan Löfås, R: Erik Walldén Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, the calScreener™ – has announced the appointment of two new highly experienced board members; Erik Walldén and […]
Sysmex Corporation (HQ: Kobe, Japan: Chairman and CEO: Hisashi Ietsugu), the Foundation for Biomedical Research and Innovation at Kobe1 (Location: Kobe, Japan; President: Tasuku Honjo) and Kyoto University (Location: Kyoto, Japan; President: Juichi Yamagiwa) have begun joint research related to the Drug Discovery Innovation Program2: Developing Technologies for Diagnosing Immunological Diseases, which the Foundation is promoting. […]
Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery Emeryville, Calif. Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has entered into a collaboration with ChemPartner Co., Ltd. (ChemPartner) focused on accelerating ChemPartner’s monoclonal antibody (mAb) discovery workflow utilizing the Beacon®Optofluidic platform. The goal is to expand ChemPartner’s antibody discovery […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH (“Navigo”) for the advancement of exclusive novel affinity ligands used in monoclonal antibody (mAb) and non-mAb downstream purification processes. Under the terms of this agreement, Repligen and Navigo will co-develop a portfolio […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
